03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Ketek* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Aventis Pharma SpA |
Origin | Italy |
Manufacturer | Aventis Pharma SPA |
Origin | Italy |
ATC | J01FA15 |
Ketek* :
Ketek* :
Ketek* :
Ketek* :
Ketek* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Ketek* :
Ketek* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Ageusia (Taste loss) | Not known |
ALT increased | Common |
Anaphylactic reactions | Not known |
Anaphylactic shock | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anosmia (smell loss) | Not known |
Arrhythmia supraventricular | Rare |
Arthralgia (Pain joint) (Joint ache) | Not known |
AST increased | Common |
Blood alkaline phosphatase increased | Common |
Bradycardia | Rare |
Confusional state | Not known |
Constipation | Uncommon |
Decreased appetite | Uncommon |
Diarrhoea (Diarrhea) | Very Common |
Diplopia | Rare |
Dizziness | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
ECG QT prolonged | Not known |
Eczema | Rare |
Eosinophilia | Uncommon |
Erythema multiforme | Very rare |
Flatulence | Common |
Flushing | Uncommon |
Gamma-GT increased | Common |
Gastrointestinal pain | Common |
Hallucination | Not known |
Headache | Common |
Hepatic enzyme increased | Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Uncommon |
Hypersensitivity | Not known |
Hypotension | Rare |
Insomnia | Uncommon |
Jaundice cholestatic (Cholestatic icterus) | Rare |
Loss of consciousness | Rare |
Muscle spasms | Very rare |
Myalgia | Not known |
Myasthenia gravis | Not known |
Nausea | Common |
Nervousness | Uncommon |
Oral candidiasis | Uncommon |
Palpitations | Uncommon |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Rare |
Parosmia | Very rare |
Pruritus | Uncommon |
Pseudomembranous colitis | Very rare |
Seizures | Not known |
Skin rash | Uncommon |
Somnolence | Uncommon |
Stomatitis | Uncommon |
Torsade de pointes | Not known |
Tremor | Not known |
Urticaria | Uncommon |
Ventricular arrhythmia | Not known |
Ventricular tachycardia | Not known |
Vertigo | Uncommon |
Vision blurred | Uncommon |
Vomiting | Common |
Vulvovaginal candidiasis | Common |
Ketek* :
NB : Products With Same Indication |
Different Units By MoH Code
Ketek* MoH 2704 :
Form | Tablet, Film-Coated |
Packaging | Blisters (Al/PVC) |
Package Size | Box of 10 |
Strength | 400mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 973856/02 |
Submission date | 01/01/2002 |
Registration Year | 2002 |
Archived Date | 2014 |
Price Comparison
● Country: | Norway | |
● Package Size: | 10 | |
● Public Price: | 375 NOK | ( 3,039,000.00 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 37,5 NOK | ( 299,848.00 LBP ) |
● Pharmacy Price: | 265.7 NOK | ( 2153232.8 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 03/06/2019 | |
● Type: | Medicine Withdrawn |
● Country: | KSA | |
● Package Size: | 10 | |
● Public Price: | 90.3 SAR | ( 2,134,692.00 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 9,03 SAR | ( 212,760.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Italy | |
● Package Size: | 10 | |
● Public Price: | 29.78 EUR | ( 2,884,967.28 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 2,978 EUR | ( 193,752.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 10 | |
● Public Price: | 23.91 EUR | ( 2,316,305.16 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 2,391 EUR | ( 193,752.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 29/04/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Belgium | |
● Package Size: | 10 | |
● Public Price: | 13.92 EUR | ( 1,348,513.92 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 1,392 EUR | ( 96,876.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 18/05/2018 | |
● Type: | Medicine Non Marketed |
● Country: | Turkey | |
● Package Size: | 10 | |
● Public Price: | 89.41 TRY | ( 239,618.80 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 8,941 TRY | ( 21,440.00 LBP ) |
● Pricing Date: | 31/12/2019 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands |
● Package Size: | 10 |
● Reference: | Zorginstituut Nederland |
● Pricing Date: | 15/06/2019 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File